Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Down 84.4% in July

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a large decrease in short interest during the month of July. As of July 31st, there was short interest totaling 7,564 shares, a decrease of 84.4% from the July 15th total of 48,491 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 247,388 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SGIOY. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Monday, June 15th. Zacks Research upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a research note on Monday, May 25th. Finally, Jefferies Financial Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Tuesday, July 14th. Two investment analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy”.

Shionogi & Co., Ltd. Unsponsored ADR Trading Down 0.2%

SGIOY traded down $0.02 during trading on Thursday, hitting $8.82. 9,270 shares of the company’s stock were exchanged, compared to its average volume of 137,814. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.65 and a 1 year high of $12.00. The stock has a 50 day moving average price of $8.78 and a 200 day moving average price of $9.87. The firm has a market cap of $15.01 billion, a P/E ratio of 8.82, a price-to-earnings-growth ratio of 3.49 and a beta of 0.08.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last released its quarterly earnings data on Monday, August 3rd. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.18. The company had revenue of $1.04 billion during the quarter, compared to analyst estimates of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.47%. As a group, analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.79 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.